ClinicalTrials.govpublic full text
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
neuroendocrine tumors, peptide receptor radionuclide treatment, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 863977
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.